1-7 of 7
Roland H. Mertelsmann, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of the Risk of Relapse and Survival Using a Conditional Survival Approach in 815 Multiple Myeloma Patients

Maximilian Schinke, Inga Promny, MD, Gabriele Ihorst, PhD, Johannes M. Waldschmidt, MD, Roland H. Mertelsmann, MD PhD, Justus Duyster, MD, Ralph M. Waesch, MD, Martin Schumacher, PhD, Monika Engelhardt, MD
Journal: Blood
Blood (2016) 128 (22): 5953.
https://doi.org/10.1182/blood.V128.22.5953.5953
Published: 2016
Journal Articles

Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Increases Overall Survival When Compared to 6 Courses of CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT in Mantle Cell Lymphoma: Final Analysis of the MCL Younger Trial of the European Mantle Cell Lymphoma Network ( MCL net )

Olivier Hermine, MD, PhD, Eva Hoster, Jan Walewski, Vincent Ribrag, MD, Nicole Brousse, M.D., Catherine Thieblemont, MD, PhD, Reda Bouabdallah, MD, Hartmut Dohner, MD, Pierre Feugier, MD, PhD, Roswitha Forspointner, MD, Corinne Haioun, MD, Michael Kneba, MD, PhD, Mathias Hänel, MD, Olivier Casasnovas, MD, Roland H. Mertelsmann, MD, PhD, Michael Hallek, MD, Andre Bosly, MD, PhD, M Nowacki, MD, Wolfram Klapper, MD PhD, Christian Gisselbrecht, MD, Bertrand Coiffier, MD, PhD, Michael Unterhalt, Wolfgang Hiddemann, MD, Martin H. Dreyling, MD
Journal: Blood
Blood (2012) 120 (21): 151.
https://doi.org/10.1182/blood.V120.21.151.151
Published: 2012
Journal Articles

Evidence for Autostimulatory Mechanisms in Chronic Lymphocytic Leukemia.

Martin Trepel, MD, PhD, Fabian Muller, MD, Mareike Frick, MD, Janina Rahlff, Claudia Wehr, Frederic Simon, PhD, Bernd Leistler, PhD, Hendrik Veelken, MD PhD, Roland H. Mertelsmann, MD, PhD, Mascha Binder, MD
Journal: Blood
Blood (2012) 120 (21): 2880.
https://doi.org/10.1182/blood.V120.21.2880.2880
Published: 2012
Journal Articles

In Vivo Efficacy of Peptide-Derived B Cell Receptor (BCR) Targeted Therapy In a Disseminated Burkitt′s Lymphoma Xenograft Modell

Claudia Wehr, Julia Schüler, Claudia Nitschke, Kerstin Klingner, Fabian Müller, Heinz-Herbert Fiebig, Roland H. Mertelsmann, MD, PhD, Martin Trepel, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3924.
https://doi.org/10.1182/blood.V116.21.3924.3924
Published: 2010
Journal Articles

B-Cell Receptor Recognition of Multiple Epitopes Correlates with An Aggressive Clinical Course of Chronic Lymphocytic Leukemia.

Mascha Binder, MD, Antje Jackst, Barbara Léchenne, Fabian Mueller, Hendrik Veelken, Roland H. Mertelsmann, MD, PhD, Martin Trepel
Journal: Blood
Blood (2009) 114 (22): 56.
https://doi.org/10.1182/blood.V114.22.56.56
Published: 2009
Journal Articles

B-Cell Receptor Profiling Suggests a Limited Number of Antigens Involved in the Pathogenesis of Chronic Lymphocytic Leukemia.

Mascha Binder, Fabian Müller, Mareike Frick, Claudia Wehr, Milena Pantic, Dietmar Pfeifer, Renata Pasqualini, Wadih Arap, MD, PhD, Hendrik Veelken, MD, Roland H. Mertelsmann, MD, PhD, Martin Trepel
Journal: Blood
Blood (2008) 112 (11): 2060.
https://doi.org/10.1182/blood.V112.11.2060.2060
Published: 2008
Journal Articles

Non-Intensive AML/MDS Treatment with Low-Dose Decitabine Prior to Reduced-Intensity Conditioning (RIC) and Allogeneic Blood Stem Cell Transplantation of Older Patients.

Michael Lübbert, MD, PhD, Hartmut Bertz, MD, PhD, Björn H. Rüter, MD, Roland H. Mertelsmann, MD, PhD, Jürgen Finke, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5257.
https://doi.org/10.1182/blood.V108.11.5257.5257
Published: 2006